---
schema_version: "secwatch.filing_event.v1"
accession: "0001062993-25-017390"
form_type: "8-K"
ticker: "INM"
cik: "0001728328"
company_name: "InMed Pharmaceuticals Inc."
filed_at: "2025-12-18T23:59:59+00:00"
generated_at: "2026-05-16T12:45:44.901596+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.25
calibrated_materiality_score: 0.25
confidence: "high"
source: SEC EDGAR
---

# InMed shareholders re-elect all five directors, approve auditor and share issuance at AGM

## Summary
- All five director nominees elected with 81.9% to 82.1% support.
- Appointment of CBIZ CPAs P.C. as auditor for 2026 approved (78.8% for).
- Shareholders approved potential issuance of >=20% of shares under SEPA with YA II PN (65.9% for).
- Turnout was 993,491 shares (35.43% of outstanding).

## SEC filing metadata
- accession: 0001062993-25-017390
- form_type: 8-K
- ticker: INM
- cik: 0001728328
- company_name: InMed Pharmaceuticals Inc.
- filed_at: 2025-12-18T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.25
- calibrated_materiality_score: 0.25
- confidence: high
- sec_items: 5.07, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1728328/000106299325017390/0001062993-25-017390-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1728328/000106299325017390/form8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001062993-25-017390
- JSON: https://secwatch.observer/filing/0001062993-25-017390.json
- Plain text: https://secwatch.observer/filing/0001062993-25-017390.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.